Metabolic Syndrome in South Asians

Overview

Journal J Clin Hypertens (Greenwich)

Specialty Cardiology & Vascular Diseases

Date 2012 Aug 7

PMID 22863165

Citations 6

Authors

C Venkata S Ram

John A Farmer

Affiliations

Soon will be listed here.

Abstract

Metabolic syndrome (MS) is a cluster of multiple cardio-metabolic risk factors in the same individual. People with MS are at high risk for the development of cardiovascular disease (CVD), chronic kidney disease (CKD), and cerebrovascular disease (CeVD). The excessive presence of MS in South Asians is likely responsible for significant morbidity in this population. This review discusses the scope of MS in South Asians and measures to combat its effects by preventive and therapeutic measures.

Citing Articles

Managing cardiovascular disease risk in South Asian kidney transplant recipients.

Prasad G, Bhamidi V World J Transplant. 2021; 11(6):147-160.

PMID: 34164291 PMC: 8218347. DOI: 10.5500/wjt.v11.i6.147.

Prevalence and correlates of metabolic syndrome among rural women in Mysore, India.

Krupp K, Adsul P, Wilcox M, Srinivas V, Frank E, Srinivas A Indian Heart J. 2020; 72(6):582-588.

PMID: 33357649 PMC: 7772584. DOI: 10.1016/j.ihj.2020.09.015.

Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3 variant.

Arif M, Nabavizadeh P, Song T, Desai D, Singh R, Bazrafshan S Biophys Rev. 2020; 12(4):1065-1084.

PMID: 32656747 PMC: 7429610. DOI: 10.1007/s12551-020-00725-1.

Effects of processed red meat consumption on the risk of type 2 diabetes and cardiovascular diseases among Korean adults: the Korean Genome and Epidemiology Study.

Son J, Lee Y, Park K Eur J Nutr. 2018; 58(6):2477-2484.

PMID: 30069618 DOI: 10.1007/s00394-018-1799-6.

Association between Toenail Mercury and Metabolic Syndrome Is Modified by Selenium.

Park K, Seo E Nutrients. 2016; 8(7).

PMID: 27420091 PMC: 4963900. DOI: 10.3390/nu8070424.

References

Enas E, Chacko V, Senthilkumar A, Puthumana N, Mohan V . Elevated lipoprotein(a)--a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review. Dis Mon. 2006; 52(1):5-50. DOI: 10.1016/j.disamonth.2006.01.002. View

Bhalodkar N, Blum S, Rana T, Bhalodkar A, Kitchappa R, Kim K . Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol. 2004; 94(12):1561-3. DOI: 10.1016/j.amjcard.2004.08.040. View

Gupta A, Gupta R, Sarna M, Rastogi S, Gupta V, Kothari K . Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract. 2003; 61(1):69-76. DOI: 10.1016/s0168-8227(03)00085-8. View

Ballantyne C, Olsson A, Cook T, Mercuri M, Pedersen T, Kjekshus J . Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001; 104(25):3046-51. DOI: 10.1161/hc5001.100624. View

Chiu K, Chuang L, Yoon C, Saad M . Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians. BMC Genet. 2000; 1:2. PMC: 29078. DOI: 10.1186/1471-2156-1-2. View

Misra A, Vikram N . Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004; 20(5):482-91. DOI: 10.1016/j.nut.2004.01.020. View

Knowler W, Fowler S, Hamman R, Christophi C, Hoffman H, Brenneman A . 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374(9702):1677-86. PMC: 3135022. DOI: 10.1016/S0140-6736(09)61457-4. View

Keech A, Simes R, Barter P, Best J, Scott R, Taskinen M . Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005; 366(9500):1849-61. DOI: 10.1016/S0140-6736(05)67667-2. View

Reddy K, Yusuf S . Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998; 97(6):596-601. DOI: 10.1161/01.cir.97.6.596. View

10.

Bhalodkar N, Blum S, Enas E . Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006; 97(7):1007-9. DOI: 10.1016/j.amjcard.2005.10.036. View

11.

Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J . Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet. 2002; 358(9299):2130-1. DOI: 10.1016/S0140-6736(01)07186-0. View

12.

Misra A, Chowbey P, Makkar B, Vikram N, Wasir J, Chadha D . Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009; 57:163-70. View

13.

Radhika G, Sathya R, Sudha V, Ganesan A, Mohan V . Dietary salt intake and hypertension in an urban south Indian population--[CURES - 53]. J Assoc Physicians India. 2007; 55:405-11. View

14.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View

15.

Manttari M, HUTTUNEN J, Koskinen P, Manninen V, Tenkanen L, Heinonen O . Lipoproteins and coronary heart disease in the Helsinki Heart Study. Eur Heart J. 1990; 11 Suppl H:26-31. DOI: 10.1093/eurheartj/11.suppl_h.26. View

16.

Ferrannini E, Haffner S, Mitchell B, Stern M . Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991; 34(6):416-22. DOI: 10.1007/BF00403180. View

17.

Eckel R, Alberti K, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2010; 375(9710):181-3. DOI: 10.1016/S0140-6736(09)61794-3. View

18.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

19.

Liu J, Sempos C, Donahue R, Dorn J, Trevisan M, Grundy S . Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care. 2005; 28(8):1916-21. DOI: 10.2337/diacare.28.8.1916. View

20.

Schernthaner G, Chilton R . Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?. Diabetes Obes Metab. 2010; 12(12):1023-35. DOI: 10.1111/j.1463-1326.2010.01262.x. View